175714-52-0

Basic information

• Product Name: 2,3,4,5-Tetrahydro-1H-benzo[d]azepine-7-carboxylic acid
• Synonyms: 2,3,4,5-Tetrahydro-1H-benzo[d]azepine-7-carboxylic acid
• CAS NO: 175714-52-0
• Molecular Formula: C11H13NO2
• Molecular Weight: 191.22642
• Mol File: 175714-52-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,3,4,5-Tetrahydro-1H-benzo[d]azepine-7-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,4,5-Tetrahydro-1H-benzo[d]azepine-7-carboxylic acid(175714-52-0)
• EPA Substance Registry System: 2,3,4,5-Tetrahydro-1H-benzo[d]azepine-7-carboxylic acid(175714-52-0)

Safety Data

• Hazardous Substances Data: 175714-52-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
2,3,4,5-Tetrahydro-1H-benzo[d]azepine-7-carboxylic acid is used as a building block in the synthesis of new therapeutic agents, particularly for the development of drugs targeting central nervous system disorders such as anxiety and depression. Its unique structure allows it to be a valuable component in creating novel drug candidates with potential therapeutic benefits.
Used as an Intermediate in Organic Synthesis:
In the chemical industry, 2,3,4,5-Tetrahydro-1H-benzo[d]azepine-7-carboxylic acid is used as an intermediate in the synthesis of other organic compounds. Its versatile chemical properties make it a useful precursor for the creation of a variety of chemical products, contributing to the development of new materials and compounds with diverse applications.

Upstream product

• 215033-43-5 3-formyl-2,3,4,5-tetrahydro-1H-3-benzazepine 
• 387876-58-6 7-acetyl-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboaldehyde 
• 4424-20-8 2,3,4,5-tetrahydro-1H-3-benzazepine 
• 387876-60-0 3-Formyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7-carboxylic acid 

Downstream Products

• 149353-73-1 3-(tert-butoxycarbonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7-carboxylic acid 

Relevant articles and documents

GPR14 ANTAGONIST

A novel GPR14 antagonist. The GPR14 antagonist comprises a compound represented by the formula (I) or a salt thereof wherein Ar represents optionally substituted aryl; X represents a spacer; n is an integer of 1 to 10; R represents an optionally substitut

USE OF POLYPEPTIDE

The present invention provides uses of a polypeptide having a ligand activity to a sensory epithelium neuropeptide-like receptor (SENR) which is a G protein-coupled receptor protein, and a DNA encoding the same. More specifically, the present invention provides an anti-attention-deficit-disorder or anti-narcolepsy agent, which comprises a polypeptide having a ligand activity for SENR or a salt thereof, as well as a method for screening compounds having an anti-attention-deficit-disorder or anti-narcolepsy activity or compounds having an anti-anxiety, anti-depression, anti-insomnia, anti-schizophrenia or anti-fear activity or salts thereof, which comprises using the above polypeptide or a precursor protein of the polypeptide or a salt thereof.

Preventives and remedies for central nervous system diseases

A prophylactic or therapeutic agent for central nervous system diseases based on amyloid β40 secretion inhibitory activity of a compound having urotensin II receptor antagonistic activity or a salt thereof.